Non-Small Cell Lung Cancer Video Channel
Explore the latest insights and summaries from experts in Non-Small Cell Lung Cancer.
Treatment Landscape
Oncology 2024 Year in Review
Year in Review 2024 - Transformative FDA Approvals in Precision Oncology Across Various Cancer Types
FEATURING
Vivek Subbiah
- 2,027 views
- December 17, 2024
- 6
Insights from 2024 WCLC
WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion
FEATURING
Pyng Lee
- 1,625 views
- September 23, 2024
- 10
Oncology 2024 Year in Review
Year in Review 2024 - NSCLC Perioperative Therapy
FEATURING
Balazs Halmos
- 854 views
- December 2, 2024
- 14
Memorial Sloan Kettering Cancer Center
Role of Surgery in Locally Advanced NSCLC
FEATURING
Katherine Gray
- 185 views
- January 17, 2025
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients With Bone Metastases
FEATURING
Robbe Van den Begin
- 710 views
- September 26, 2024
- 8
ecancer
ESMO 2024 Summary: Key Trial Insights on Managing NSCLC With Low PD-L1 Expression
FEATURING
Luis Paz-Ares
- 183 views
- February 3, 2025
- 1
University of Colorado Cancer Center
Metastatic EGFRm NSCLC: 1L Therapy Options
FEATURING
Tejas Patil
- 496 views
- October 11, 2024
- 7
Fox Chase Cancer Center
IO Advances in Metastatic NSCLC Treatment
FEATURING
Hossein Borghaei
- 238 views
- January 2, 2025
- 3
Oncology 2024 Year in Review
Year in Review 2024 - Top Clinical Trials in Neuro-Oncology
FEATURING
Stephen Bagley
- 299 views
- December 20, 2024
- 2
Fox Chase Cancer Center
Unresectable Stage 3 NSCLC: Patient Selection and Treatment Options
FEATURING
Charu Aggarwal
- 175 views
- January 2, 2025
- 2
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New Treatments
FEATURING
Guru Sonpavde
- 2,202 views
- April 16, 2024
- 12
David Carbone
Multidisciplinary Panel Discussion: New Treatment Options for Surgically Resectable NSCLC
FEATURING
Brendon Stiles
- 353 views
- October 21, 2024
- 5
Nebraska Oncology Society
Year in Review 2024 - Targeted Therapy for NSCLC
FEATURING
Joseph Murray
- 188 views
- January 5, 2025
- 1
ecancer
ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON, REZILIENT1, LAURA, and SKIPPirr
- 353 views
- October 11, 2024
- 3
Insights from 2024 WCLC
WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Therapy Debate in NSCLC
FEATURING
Jan Von Der Thusen
- 262 views
- October 21, 2024
- 6
Insights from 2024 WCLC
WCLC 2024 Insights: Interstitial Lung Disease and Lung Cancer - How Should We Proceed
FEATURING
Satoshi Ikeda
- 377 views
- September 23, 2024
- 2
Total Health
2024 Intervention Selection & Sequencing in Early Stage NSCLC
FEATURING
Jason Porter
- 1,330 views
- February 23, 2024
- 7
Total Health
Treatment Updates in Early Stage NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 202 views
- October 29, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials
FEATURING
Luis Raez
- 728 views
- June 14, 2024
- 5
Total Health
Treatment Updates in Advanced and Metastatic NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 184 views
- October 29, 2024
- 1
UNC Lineberger Comprehensive Cancer Center
Treatment Strategies for Metastatic HER2-Mutant NSCLC
FEATURING
Shetal Patel
- 78 views
- December 3, 2024
- 1
Fox Chase Cancer Center
EGFR Mutations in NSCLC: Latest Updates and Key Changes
FEATURING
Joseph Bodor
- 125 views
- December 16, 2024
- 2
MI&T Congressi
Options for Osimertinib-Resistant NSCLC
FEATURING
Trever Bivona
- 212 views
- September 3, 2024
- 4
GRACE
Advancing Treatment in EGFR-Mutated NSCLC: Results From FLAURA2 and MARIPOSA Trials
FEATURING
Aakash Desai,
Fawzi Abu Rous
- 118 views
- December 1, 2024
- 1
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: NSCLC
FEATURING
Rajat Thawani
- 283 views
- August 27, 2024
- 4
Yale Cancer Center
Resectable NSCLC: Perioperative Immunotherapy and Multidisciplinary Care
FEATURING
Gavitt Woodard
- 75 views
- January 14, 2025
Giannis Mountzios
New Frontiers in NSCLC Treatment: Expanding Options Beyond Chemo-Immunotherapy and Docetaxel
- 328 views
- August 20, 2024
- 4
Oncology Data Advisor
World Lung Cancer Day: Key Insights and Advances in Lung Cancer Treatment and Research
- 163 views
- September 11, 2024
- 1
Yale Cancer Center
Key Metastatic NSCLC Trial Updates Including MARIPOSA and FLAURA2
FEATURING
Sarah Goldberg
- 122 views
- October 21, 2024
- 1
Luis Raez
Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage Disease
- 509 views
- May 27, 2024
- 5
Integrity CE
Management of mNSCLC Without Actionable Mutations
FEATURING
Megan Baumgart,
Stephen Liu
- 131 views
- September 3, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Summary: Comparing Treatment for Locally Advanced NSCLC - Debate Overview
FEATURING
Jessica Donington
- 159 views
- September 23, 2024
- 2
Yale Cancer Center
Key Advances in Lung Cancer Therapies: A Comprehensive Overview
FEATURING
Anne Chiang
- 72 views
- January 14, 2025
ecancer
ESMO and WCLC Updates on Common EGFR Mutations in NSCLC: Panel Discussion
- 87 views
- January 16, 2025
- 1
Integrity CE
Management of Stage IV NSCLC With Actionable Mutations
FEATURING
Grace Dy
- 186 views
- September 3, 2024
- 3
Integrity CE
How the Experts Treat: Early Stage NSCLC With Curative Intent
FEATURING
Stephen Liu
- 150 views
- August 8, 2024
Nebraska Oncology Society
Year in Review 2024 - Perioperative Immunotherapy in Resectable NSCLC
FEATURING
Joseph Murray
- 55 views
- January 5, 2025
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Addition of Cytotoxic Chemotherapy to Targeted Therapy in NSCLC
FEATURING
Bruna Pellini
- 153 views
- October 1, 2024
- 1
Lung Cancer Europe (LuCE)
Targeted Therapy and Oncogene Addiction in Lung Cancer: New Developments
FEATURING
Benjamin Besse
- 94 views
- November 11, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Current and Future Use of EGFR-Targeted Agents in Lung Cancer
FEATURING
Pilar Garrido
- 167 views
- September 26, 2024
- 1
Yale Cancer Center
2024 Updates on NSCLC Targeted Therapies: FLAURA2 Trial - Osimertinib + Chemo vs. Osimertinib Alone for Advanced EGFRm Disease
FEATURING
Pasi Janne
- 702 views
- February 23, 2024
- 3
Dionysis Papadatos-Pastos
Optimizing Treatment Intensification in 1L EGFR-Mutated NSCLC
- 143 views
- September 26, 2024
Federico Cappuzzo
Current & Future Directions of IO in Early Stage NSCLC
- 123 views
- October 17, 2024
- 1
MI&T Congressi
Neoadjuvant Chemoimmunotherapy in Unresectable NSCLC
FEATURING
Isabelle Opitz
- 158 views
- August 20, 2024
- 2
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-671
FEATURING
Luis Raez
- 910 views
- February 23, 2024
- 5
Total Health
2024 Updates on the Fast-Changing NSCLC Landscape
FEATURING
Raymond Osarogiagbon
- 452 views
- February 23, 2024
- 4
Insights from 2024 WCLC
WCLC 2024 Insights: Management of Brain Metastases in Oncogene-Driven NSCLC - Timing, Sequency, and Modality of RT
FEATURING
Joe Chang
- 128 views
- September 18, 2024
Insights from 2024 WCLC
WCLC 2024 Summary: Intensifying Suboptimal Response to Targeted Therapy for NSCLC - Rational Targeted Combinations
FEATURING
Melina Marmarelis
- 112 views
- September 23, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Highlights of Coming Advances in mNSCLC - Cytotoxics, IO, and KRAS Inhibitors
FEATURING
Brian Henick
- 119 views
- September 19, 2024
ecancer
ESMO 2024 Review: Amivantamab ± Chemo in EGFRm aNSCLC Post-Osimertinib - MARIPOSA-2 Interim OS
FEATURING
Enriqueta Felip
- 39 views
- January 21, 2025
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Metastatic Setting
FEATURING
Michael Hwang
- 1,053 views
- December 13, 2023
- 13
MI&T Congressi
Neoadjuvant and Adjuvant Therapies in NSCLC: Are We Saving Lives?
FEATURING
Giorgio Scagliotti
- 189 views
- July 22, 2024
- 4
MI&T Congressi
How the Experts Treat: Adjuvant or Neoadjuvant Immunotherapy for NSCLC
FEATURING
Tina Cascone
- 147 views
- July 24, 2024
- 2
University of Illinois Cancer Center
Navigating Neoadjuvant Options for Early Stage Lung Cancer: Current Updates in the Perioperative Treatment
FEATURING
Frank Weinberg
- 47 views
- December 5, 2024
- 1
Yale Cancer Center
Key NSCLC Trial Updates Including ADAURA and KEYNOTE-671
FEATURING
Sarah Goldberg
- 70 views
- October 21, 2024
- 1
MI&T Congressi
How the Experts Treat: Neoadjuvant or Adjuvant Targeted Therapy in Resectable Oncogene-Addicted NSCLC
FEATURING
Jarushka Naidoo
- 167 views
- July 12, 2024
- 2
Shirish Gadgeel
Advancing Treatment Strategies for ALK-Positive Advanced NSCLC
- 39 views
- November 27, 2024
- 1
University of Illinois Cancer Center
Precision Oncology: Leveraging Biomarkers for 1L Treatment in mNSCLC
FEATURING
Ryan Nguyen
- 54 views
- December 5, 2024
- 1
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Updates on Metastatic ALK+ NSCLC
FEATURING
Vincent Lam
- 78 views
- September 11, 2024
Fred Hutchinson Cancer Center
Practical Guidelines on Testing & Treatment of BRAF V600+ NSCLC
FEATURING
Christina Baik
- 104 views
- August 28, 2024
- 1
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "The Latest Data in Oncogene-Addicted NSCLC"
FEATURING
Nicolas Girard
- 199 views
- July 11, 2024
- 1
Springer Healthcare IME
Advancements in Tumor-Agnostic Cancer Treatment: Expert Panel Discussion
- 91 views
- October 29, 2024
- 1
MI&T Congressi
Optimal Duration of Immunotherapy in NSCLC
FEATURING
Giulia Pasello
- 102 views
- August 20, 2024
- 1
North American Neuroendocrine Tumor Society
Demystifying Thoracic Neuroendocrine Neoplasms: Key Management Differences in TC, AC, LCNEC, and SCLC
FEATURING
Robert Ramirez
- 86 views
- September 10, 2024
- 1
Brendon Stiles
Surgical Dogma, Reality, and Aspirations After Neoadjuvant Therapy for NSCLC
- 224 views
- April 29, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Summary: Survival Outcomes and Pathologic Response After Chemoimmunotherapy in Resectable NSCLC
FEATURING
Daniele Marinelli
- 56 views
- September 18, 2024
- 2
Yale Cancer Center
Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanced NSCLC
FEATURING
Amin Nassar
- 489 views
- February 7, 2024
- 2
Insights from 2023 ESMO Annual Meeting
Perioperative Immunotherapy Strategies in Resectable NSCLC After ESMO 2023
FEATURING
Giannis Mountzios
- 748 views
- October 30, 2023
- 14
GRACE
Advancing Treatment in EGFR-Mutated NSCLC: Results From MARIPOSA2 and LAURA Trials
FEATURING
Aakash Desai,
Fawzi Abu Rous
- 29 views
- December 1, 2024
Scripps Health
2024 Neuro-Oncology Update: NSCLC and Brain Mets
FEATURING
Tresa McGranahan
- 363 views
- April 2, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Local Consolidative Therapy for Oligometastatic NSCLC
FEATURING
Vincent Lam
- 68 views
- September 11, 2024
Luis Raez
Oligometastatic Lung Cancer & Stereotactic Radiation Therapy Utilization
- 174 views
- May 27, 2024
MI&T Congressi
How the Experts Treat: Adjuvant Immunotherapy for Resected NSCLC
FEATURING
Dolores Isla
- 94 views
- July 18, 2024
- 2
ecancer
ELCC 2024 Roundtable: "Latest Updates in EGFR Mutant NSCLC With a Focus on Exon 20 Mutation"
- 209 views
- May 1, 2024
- 2
OncoAlert
mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC
FEATURING
Charu Aggarwal
- 387 views
- February 15, 2024
- 2
Yale Cancer Center
Progress in the Treatment of NSCLC
FEATURING
Roy Herbst
- 509 views
- December 20, 2023
- 3
MI&T Congressi
How the Experts Treat: Neoadjuvant Immunotherapy for Resected NSCLC
FEATURING
Mariano Provencio Pulla
- 87 views
- July 24, 2024
- 1
GRACE
Perioperative Therapies for Resectable NSCLC
FEATURING
Millie Das
- 332 views
- February 15, 2024
- 2
Maen Hussein
Improving Outcomes in NSCLC: Treatment and Prognostication Updates
- 295 views
- February 23, 2024
- 7
Rush University Medical Center
Current Unmet Needs and Challenges in 1L Treatment Approaches for EGFRm NSCLC
FEATURING
Mary Fidler
- 313 views
- February 28, 2024
- 2
ecancer
ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials
FEATURING
Luis Raez
- 68 views
- July 2, 2024
- 1
OncoAlert
Thoracic Surgery Updates From Recent NSCLC Trials
FEATURING
Brendon Stiles
- 313 views
- February 15, 2024
- 1
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 105 views
- July 2, 2024
- 1
Yale Cancer Center
Lung Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Therapy
FEATURING
Charles Balch
- 175 views
- April 3, 2024
- 1
Yale Cancer Center
Year in Review: Progress in NSCLC Treatment
FEATURING
Roy Herbst
- 661 views
- October 22, 2023
- 7
OncoAlert
Early NSCLC Updates: EGFRm, ALK+ Disease & Neoadjuvant IO
FEATURING
Gilberto Lopes
- 244 views
- February 15, 2024
- 3
ecancer
ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"
FEATURING
Bishal Gyawali
- 404 views
- November 15, 2023
- 7
Total Health
Selected Targeted Therapies in NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 30 views
- October 29, 2024
Insights from ELCC 2024
ELCC 2024 Summary: "Combining New Drugs and RT in Lung Cancer"
FEATURING
Deborah Zhou
- 166 views
- April 10, 2024
2023 Evolution Conference
IO and Targeted Treatment for mNSCLC
FEATURING
Meghan Mooradian
- 466 views
- November 8, 2023
- 2
Yale Cancer Center
Treatment Approach to ROS1 Rearranged NSCLC
FEATURING
Michael Grant
- 525 views
- October 19, 2023
- 2
Robert Hsu
Unmet Need in NSCLC Treatment Options Following Progression on 1L IO + Chemo
- 437 views
- November 15, 2023
- 4
Insights from ELCC 2024
ELCC 2024 Insights: "Treatment Landscape for Stages I-III NSCLC in the US Community Setting Before and After 2020"
FEATURING
Jessica Donington
- 142 views
- April 11, 2024
- 2
COR2ED The Heart of Medical Education
Oncogene-Addicted NSCLC Highlights From WCLC & ESMO 2024
FEATURING
Herbert Loong
- 39 views
- October 28, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Updates on Locally Advanced EGFR-Mutated NSCLC
FEATURING
Vincent Lam
- 42 views
- August 13, 2024
ecancer
ESMO 2024 Summary: Highlights & Analysis of the Biggest Solid Cancer Updates
FEATURING
Bishal Gyawali
- 48 views
- October 21, 2024
COR2ED The Heart of Medical Education
ESMO 2024 Summary: BRAF-Altered Lung Cancer
FEATURING
Federico Cappuzzo,
David Planchard
- 33 views
- October 25, 2024
Yale Cancer Center
GI Oncology Year in Review: Key mCRC Studies Including CheckMate 8HW & CodeBreaK 300
FEATURING
Michael Cecchini
- 115 views
- March 11, 2024
- 1
Total Health
West Cancer Center Updates on NSCLC
FEATURING
Jason Porter
- 195 views
- December 15, 2023
- 1
North American Neuroendocrine Tumor Society
Medical Therapy Options for Lung NETs
FEATURING
Robert Ramirez
- 33 views
- September 10, 2024
2023 Evolution Conference
Treatment Strategies for Early Stage NSCLC
FEATURING
Nagashree Seetharamu
- 314 views
- November 8, 2023
- 2
Fox Chase Cancer Center
Role of Radiation in the Management of Oligoprogressive NSCLC
FEATURING
Randi Cohen
- 10 views
- January 8, 2025
Insights from 2023 WCLC
WCLC 2023 Insights: "5-Year Survival of Pembro + Chemo for mNSCLC With PD-L1 Tumor Proportion Score <1%"
FEATURING
Shirish Gadgeel
- 305 views
- October 9, 2023
- 1
Yale Cancer Center
2024 Updates on NSCLC Targeted Therapies: New Drug Targets in EGFRm Disease - TROP2
FEATURING
Pasi Janne
- 119 views
- February 23, 2024
- 2
ecancer
ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consolidative Therapy in Limited mNSCLC"
FEATURING
Puneeth Iyengar
- 38 views
- July 2, 2024
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Recent Developments in the Treatment of Patients With EGFR ex 20 Ins NSCLC"
FEATURING
Paul Mitchell
- 307 views
- November 10, 2023
- 1
ecancer
ESMO 2023 Insights: "The Latest in NSCLC With Common EGFR Mutations"
- 315 views
- October 25, 2023
- 2
UNC Lineberger Comprehensive Cancer Center
Treatment Strategies for Metastatic KRAS-Mutant NSCLC
FEATURING
Shetal Patel
- 7 views
- December 3, 2024
Memorial Sloan Kettering Cancer Center
Radiation for Unresectable NSCLC: Where Are We Now and Where Are We Going
FEATURING
Daniel Gomez
- 149 views
- December 13, 2023
- 3
ImmunoTherapy Bridge 2023
What’s New in NSCLC & Mesothelioma Immunotherapy
FEATURING
Alessandro Morabito
- 120 views
- January 19, 2024
- 2
MI&T Congressi
Radiotherapy for N2 Resected NSCLC
FEATURING
Cécile Le Péchoux
- 31 views
- July 12, 2024
- 1
Integrity CE
The Evolving Treatment Journey for Patients With Unresectable Stage III NSCLC in the Era of Immune Therapy
FEATURING
Ticiana Leal
- 93 views
- January 26, 2024
OncoAlert
Year in Review: Lung Cancer Radiation Therapy
FEATURING
Charles Simone
- 115 views
- February 15, 2024
- 1
MI&T Congressi
Potential Role of ADC in Early Stage NSCLC
FEATURING
Enriqueta Felip
- 35 views
- September 3, 2024
OncoAlert
Year in Review: Colorectal and Anal Cancers
FEATURING
Cathy Eng
- 59 views
- February 22, 2024
COR2ED The Heart of Medical Education
Key Highlights: Testing to Treatment of BRAF-Mutant Metastatic NSCLC
FEATURING
Federico Cappuzzo,
David Planchard
- 6 views
- February 3, 2025
ImmunoTherapy Bridge 2023
IO in Metastatic Non-Oncogene Addicted NSCLC: Consolidated Options to Cover the Unmet Need
FEATURING
Alessandro Morabito
- 96 views
- January 9, 2024
COR2ED The Heart of Medical Education
Testing to Treatment of BRAF-Mutant Metastatic NSCLC
FEATURING
Federico Cappuzzo,
David Planchard
- 8 views
- February 3, 2025
GRACE
Leveraging AI and Precision Oncology to Optimize Synergy Between Local and Systemic Therapies in the Management of Metastatic NSCLC
FEATURING
Puneeth Iyengar
- 65 views
- February 15, 2024
- 1
ImmunoTherapy Bridge 2023
Best of SITC 2023 for Clinical Development and IO Trials
FEATURING
Paolo A. Ascierto
- 94 views
- January 11, 2024
- 1
OncoAlert
Updates in Targeted Therapies for Solid Tumors
FEATURING
Benedikt Westphalen
- 66 views
- February 17, 2024
OncoAlert
Immunotherapy Highlights for Solid Tumors in 2023
FEATURING
John Haanen
- 58 views
- February 16, 2024
ImmunoTherapy Bridge 2023
Updates on Radiation and Immunotherapy
FEATURING
Silvia Formenti
- 72 views
- January 9, 2024
- 1
Insights from 2023 ESMO Asia Annual Meeting
ESMO Asia 2023 Insights: "EGFR TKIs in NSCLC - Which One, How Long, When, and Who"
FEATURING
Masahiro Tsuboi
- 54 views
- January 3, 2024
- 1
ecancer
ESMO and WCLC Updates on EGFR Exon 20 Insertion in NSCLC: Panel Discussion
- 11 views
- January 21, 2025
Lorenzo Belluomini
Selpercatinib in Patients With RET Fusion-Positive NSCLC: Where Are We Now?
- 62 views
- December 22, 2023
- 1
GRACE
Local Therapy for Patients With Oligoprogressive NSCLC
FEATURING
Puneeth Iyengar
- 48 views
- February 13, 2024
GRACE
Local Therapy for Oligometastatic NSCLC Patients After Frontline Therapy
FEATURING
Puneeth Iyengar
- 41 views
- February 13, 2024
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Contemporary LMD Clinical Trials: Design and Landscape
FEATURING
Priya Kumthekar
- 17 views
- April 30, 2024
GRACE
Using Radiation to Improve Outcomes and QoL in Patients With mNSCLC
FEATURING
Puneeth Iyengar
- 9 views
- May 15, 2024
ecancer
ESMO 2024 Review: Osimertinib After CRT in Unresectable Stage 3 EGFRm NSCLC - CNS and Distant Progression Results From LAURA
FEATURING
Enriqueta Felip
- 4 views
- January 21, 2025
GRACE
EGFRm Lung Cancer: Overview & Treatment Sequence
FEATURING
Julia Rotow
- 1 view
- February 21, 2025